Elevance Health, Inc.
ELVNYSECIK 1156039FinancialsFiscal year ends Dec 31
Latest reported revenue, Q3 FY2026$51.43bnRevenue, Q3 FY2026, three months to 2026-09-30$51.43bn. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figureThree months to Sep 30, 2026, from the 10-Q filed Oct 21, 2026.Latest quarter: Q3 FY2026
Three months to Sep 30, 2026, against the same quarter a year earlier.
- Revenue$51.43bnRevenue, Q3 FY2026, three months to 2026-09-30$51.43bn. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure+1.4% on a year earlier - Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
- Operating margin2.5%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: $1.27bn. XBRL concept
us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Revenue: $51.43bn. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure−0.1 pts on a year earlier - Net margin2.7%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $1.36bn. XBRL concept
us-gaap:NetIncomeLoss. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Revenue: $51.43bn. XBRL conceptus-gaap:Revenues. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure+0.3 pts on a year earlier - Diluted EPS$6.27Diluted EPS, Q3 FY2026, three months to 2026-09-30$6.27 per share. XBRL concept
us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure+17.9% on a year earlier - Free cash flow$1.00bnFree cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $1.27bn. XBRL concept
us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-21, accession 0001156039-26-000071. Derived: 9-month figure less the 6-month figure.Capital expenditure: $267.0m. XBRL conceptus-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-21, accession 0001156039-26-000071. Derived: 9-month figure less the 6-month figure.Report this figure+29.0% on a year earlier
Last eight quarters
Full statements| Line item | Unit | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 | Q3 FY20262026-09-30 | Shape over the periods |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $bn | 45.4Revenue, Q4 FY2024, three months to 2024-12-31$45.44bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 48.9Revenue, Q1 FY2025, three months to 2025-03-31$48.89bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Report this figure | 49.8Revenue, Q2 FY2025, three months to 2025-06-30$49.78bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Report this figure | 50.7Revenue, Q3 FY2025, three months to 2025-09-30$50.71bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure | 49.7Revenue, Q4 FY2025, three months to 2025-12-31$49.75bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 50.2Revenue, Q1 FY2026, three months to 2026-03-31$50.18bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Report this figure | 50.5Revenue, Q2 FY2026, three months to 2026-06-30$50.47bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Report this figure | 51.4Revenue, Q3 FY2026, three months to 2026-09-30$51.43bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure | |
| Gross margin | % | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | |
| Operating margin | % | 1.5%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $673.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $45.44bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 6.5%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $3.17bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Revenue: $48.89bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Report this figure | 4.9%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $2.42bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Revenue: $49.78bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Report this figure | 2.6%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $1.29bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Revenue: $50.71bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure | 0.6%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $309.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $49.75bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 4.2%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $2.09bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Revenue: $50.18bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Report this figure | 3.5%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $1.76bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Revenue: $50.47bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Report this figure | 2.5%Operating margin, Q3 FY2026, three months to 2026-09-30. operating income / revenueOperating income: $1.27bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Revenue: $51.43bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure | |
| Net margin | % | 0.9%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $418.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $45.44bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 4.5%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $2.18bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Revenue: $48.89bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Report this figure | 3.5%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $1.74bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Revenue: $49.78bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Report this figure | 2.3%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $1.19bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Revenue: $50.71bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure | 1.1%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $547.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Revenue: $49.75bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 3.5%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $1.76bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Revenue: $50.18bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Report this figure | 2.9%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $1.46bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Revenue: $50.47bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Report this figure | 2.7%Net margin, Q3 FY2026, three months to 2026-09-30. net income / revenueNet income: $1.36bn. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Revenue: $51.43bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | 9.61Diluted EPS, Q1 FY2025, three months to 2025-03-31$9.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Report this figure | 7.72Diluted EPS, Q2 FY2025, three months to 2025-06-30$7.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Report this figure | 5.32Diluted EPS, Q3 FY2025, three months to 2025-09-30$5.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure | not reported (Diluted EPS not reported) | 8.00Diluted EPS, Q1 FY2026, three months to 2026-03-31$8.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Report this figure | 6.71Diluted EPS, Q2 FY2026, three months to 2026-06-30$6.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-15, accession 0001156039-26-000060.Report this figure | 6.27Diluted EPS, Q3 FY2026, three months to 2026-09-30$6.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-10-21, accession 0001156039-26-000071.Report this figure | |
| Free cash flow | $bn | 0.4Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $706.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Capital expenditure: $322.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 0.8Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $1.02bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Capital expenditure: $196.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Report this figure | 1.8Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $2.05bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-15, accession 0001156039-26-000060. Derived: 6-month figure less the 3-month figure.Capital expenditure: $267.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-15, accession 0001156039-26-000060. Derived: 6-month figure less the 3-month figure.Report this figure | 0.8Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $1.14bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-21, accession 0001156039-26-000071. Derived: 9-month figure less the 6-month figure.Capital expenditure: $360.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-21, accession 0001156039-26-000071. Derived: 9-month figure less the 6-month figure.Report this figure | (0.2)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $84.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Capital expenditure: $293.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-06, accession 0001156039-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure | 4.1Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $4.33bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Capital expenditure: $235.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-22, accession 0001156039-26-000043.Report this figure | 1.6Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $1.91bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-15, accession 0001156039-26-000060. Derived: 6-month figure less the 3-month figure.Capital expenditure: $287.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-15, accession 0001156039-26-000060. Derived: 6-month figure less the 3-month figure.Report this figure | 1.0Free cash flow, Q3 FY2026, three months to 2026-09-30. operating cash flow − capital expenditureOperating cash flow: $1.27bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-10-21, accession 0001156039-26-000071. Derived: 9-month figure less the 6-month figure.Capital expenditure: $267.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-10-21, accession 0001156039-26-000071. Derived: 9-month figure less the 6-month figure.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY20212021-12-31 | FY20222022-12-31 | FY20232023-12-31 | FY20242024-12-31 | FY20252025-12-31 | Shape over the periods |
|---|---|---|---|---|---|---|---|
| Revenue | $bn | 139Revenue, FY2021, twelve months to 2021-12-31$138.64bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-21, accession 0001156039-24-000015.Report this figure | 157Revenue, FY2022, twelve months to 2022-12-31$156.59bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-20, accession 0001156039-25-000010.Report this figure | 171Revenue, FY2023, twelve months to 2023-12-31$171.34bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | 177Revenue, FY2024, twelve months to 2024-12-31$177.01bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | 199Revenue, FY2025, twelve months to 2025-12-31$199.13bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | |
| Gross margin | % | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | |
| Operating margin | % | 5.5%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $7.56bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-21, accession 0001156039-24-000015.Revenue: $138.64bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-21, accession 0001156039-24-000015.Report this figure | 5.3%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $8.28bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-20, accession 0001156039-25-000010.Revenue: $156.59bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-20, accession 0001156039-25-000010.Report this figure | 5.0%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $8.50bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-06, accession 0001156039-26-000013.Revenue: $171.34bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | 4.4%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $7.86bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-06, accession 0001156039-26-000013.Revenue: $177.01bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | 3.6%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $7.20bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-06, accession 0001156039-26-000013.Revenue: $199.13bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | |
| Net margin | % | 4.4%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $6.16bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-21, accession 0001156039-24-000015.Revenue: $138.64bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-21, accession 0001156039-24-000015.Report this figure | 3.8%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $5.89bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-20, accession 0001156039-25-000010.Revenue: $156.59bn. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-20, accession 0001156039-25-000010.Report this figure | 3.5%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $5.99bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-06, accession 0001156039-26-000013.Revenue: $171.34bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | 3.4%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $5.98bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-06, accession 0001156039-26-000013.Revenue: $177.01bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | 2.8%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $5.66bn. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-06, accession 0001156039-26-000013.Revenue: $199.13bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | |
| Diluted EPS | $ per share | 24.95Diluted EPS, FY2021, twelve months to 2021-12-31$24.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-21, accession 0001156039-24-000015.Report this figure | 24.28Diluted EPS, FY2022, twelve months to 2022-12-31$24.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-20, accession 0001156039-25-000010.Report this figure | 25.22Diluted EPS, FY2023, twelve months to 2023-12-31$25.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | 25.68Diluted EPS, FY2024, twelve months to 2024-12-31$25.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | 25.21Diluted EPS, FY2025, twelve months to 2025-12-31$25.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | |
| Free cash flow | $bn | 7.3Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $8.36bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-21, accession 0001156039-24-000015.Capital expenditure: $1.09bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-21, accession 0001156039-24-000015.Report this figure | 7.2Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $8.40bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-20, accession 0001156039-25-000010.Capital expenditure: $1.15bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-20, accession 0001156039-25-000010.Report this figure | 6.8Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $8.06bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-06, accession 0001156039-26-000013.Capital expenditure: $1.30bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | 4.6Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $5.81bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-06, accession 0001156039-26-000013.Capital expenditure: $1.26bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure | 3.2Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $4.29bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-06, accession 0001156039-26-000013.Capital expenditure: $1.12bn. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-06, accession 0001156039-26-000013.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 273 | $447.19 | $122.1k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 827 | $446.05 | $368.9k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 160 | $444.85 | $71.2k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 440 | $443.81 | $195.3k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 480 | $442.61 | $212.5k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 2,343 | $441.34 | $1.0m | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 1,720 | $440.44 | $757.6k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 1,160 | $439.25 | $509.5k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 240 | $438.22 | $105.2k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 560 | $437.07 | $244.8k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 1,660 | $436.20 | $724.1k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 321 | $435.25 | $139.7k | Form 4 |
| 2026-10-22 | Kaye MarkEVP & CFO, Officer | Sale | 400 | $434.00 | $173.6k | Form 4 |
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2026-06-30 | $7.34bn | 18,991,090 | Reduced−896,021 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 2026-06-30 | $5.44bn | 14,058,204 | Reduced−287,255 | |
| STATE STREET CORP | 2026-06-30 | $4.03bn | 10,426,610 | Added+137,914 | |
| WELLINGTON MANAGEMENT GROUP LLP | 2026-06-30 | $3.56bn | 9,213,513 | Added+984,976 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2026-06-30 | $2.40bn | 6,214,356 | Reduced−141,721 | |
| Sanders Capital, LLC | 2026-06-30 | $2.25bn | 5,825,024 | Reduced−69,279 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-06-30 | $1.99bn | 5,166,124 | Reduced−26,583 | |
| HARRIS ASSOCIATES L P | 2026-06-30 | $1.90bn | 4,924,511 | Added+127,985 | |
| Artisan Partners Limited Partnership | 2026-06-30 | $1.77bn | 4,581,222 | Reduced−545,953 | |
| Invesco Ltd. | 2026-06-30 | $1.64bn | 4,234,231 | Reduced−583,179 |
Recent filings
All 1,507 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2118:14 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001156039-26-000071 |
| 2026-10-2110:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-26-000068 |
| 2026-09-1010:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001156039-26-000063 |
| 2026-07-1515:27 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001156039-26-000060 |
| 2026-07-1510:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-26-000058 |
| 2026-06-1010:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001156039-26-000049 |
| 2026-05-1320:07 ET | 8-K | 5.07 Shareholder vote results | 0001156039-26-000046 |
| 2026-04-2214:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001156039-26-000043 |
| 2026-04-2210:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001156039-26-000039 |
| 2026-03-2720:21 ET | DEF 14A | Proxy statementPeriod 2026-05-13 | 0001156039-26-000031 |
Latest annual report
Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 6, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league
About the filer
- CIK
- 1156039
- Tickers
- ELV
- Exchange
- NYSE
- SIC code
- 6324 Hospital & Medical Service Plans
- Sector
- Financials
- Fiscal year ends
- Dec 31
- Incorporated in
- IN
- Filer category
- Large accelerated filer
- Former names
- Anthem, Inc. (to 2022-06-24); WELLPOINT, INC (to 2014-11-12); WELLPOINT INC (to 2009-12-21); ANTHEM INC (to 2004-11-30)
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:34 ET. Listed shows no prices and gives no investment advice.